Momentum for cannabis stocks continues to intensify, as international acceptance instils confidence in companies to develop and distribute legal products. The confidence in the market was highlighted on Wednesday this…
Growing revenues put Creso Pharma in box seat to capitalise on positive cannabis momentum Listed cannabis company Creso Pharma Ltd. (ASX: CPH) looks to have started 2021 as it finished…
Last week, Creso Pharma Limited’s (ASX:CPH; FRA: 1X8) wholly-owned Canadian cannabis cultivation subsidiary, Mernova Medicinal Inc. received three purchase orders with a combined value of C$275,023 (A$288,159). These new purchase…
Creso Pharma Limited (ASX:CPH; FRA: 1X8) has had a promising week following positive regulatory changes by both the United Nations Commission on Narcotic Drugs and the Court of Justice of…
Though it has had its issues over the past 12 months following the failed A$122M acquisition by TSX listed cannabis company PhamaCielo, Creso Pharma (ASX: CPH) may be turning the…
